Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
PTC Therapeutics (BH3.XETRA) Q2 2026 Earnings
BH3.XETRA
7
May
Confirmed
Q2 2026
-0.4
-0.28
-0.15
-0.03
Details
Expected EPS
-0.40223513512000003
Actual EPS
-0.0255801
Surprise EPS
0.38
Surprise Percent
+93.64%
Description
PTC Therapeutics (BH3.XETRA) has reported earnings of -0.0255801 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login